Aspirin suppresses the mutator phenotype associated with hereditary nonpolyposis colorectal cancer by genetic selection.

Nonsteroidal anti-inflammatory drugs (NSAIDs) are well-known cancer preventives, which have been largely attributed to their antiproliferative and apoptosis-inducing activities. In this study, we show that microsatellite instability (MSI) in colorectal cancer cells deficient for a subset of the human mismatch repair (MMR) genes (hMLH1, hMSH2, and hMSH6), is markedly reduced during exposure to aspirin or sulindac [or Clinoril, which is chemically related to indomethacin (Indocin)]. This effect was reversible, time and concentration dependent, and appeared independent of proliferation rate and cyclooxygenase function. In contrast, the MSI phenotype of a hPMS2-deficient endometrial cancer cell line was unaffected by aspirin/sulindac. We show that the MSI reduction in the susceptible MMR-deficient cells was confined to nonapoptotic cells, whereas apoptotic cells remained unstable and were eliminated from the growing population. These results suggest that aspirin/sulindac induces a genetic selection for microsatellite stability in a subset of MMR-deficient cells and may provide an effective prophylactic therapy for hereditary nonpolyposis colorectal cancer kindreds where alteration of the hMSH2 and hMLH1 genes are associated with the majority of cancer susceptibility cases.

[1]  D. Cramer,et al.  Over-the-counter analgesics and risk of ovarian cancer , 1998, The Lancet.

[2]  S. Pignata,et al.  Effect of aspirin on cell proliferation and differentiation of colon adenocarcinoma Caco‐2 cells , 1997, International journal of cancer.

[3]  J. Rüschoff,et al.  Diagnostic microsatellite instability: definition and correlation with mismatch repair protein expression. , 1997, Cancer research.

[4]  M. Koike,et al.  Germline mutation of MSH6 as the cause of hereditary nonpolyposis colorectal cancer , 1997, Nature Genetics.

[5]  R. DuBois,et al.  Aspirin use and potential mechanisms for colorectal cancer prevention. , 1997, The Journal of clinical investigation.

[6]  Y. Yuasa,et al.  Germ-line mutation of the hMSH6/GTBP gene in an atypical hereditary nonpolyposis colorectal cancer kindred. , 1997, Cancer research.

[7]  M. Meuth,et al.  Conditional mutator phenotypes in hMSH2-deficient tumor cell lines. , 1997, Science.

[8]  R. Sjödahl,et al.  Cyclo-oxygenase and colon cancer: clues to the aspirin effect? , 1997, Annals of medicine.

[9]  T. Petes,et al.  Microsatellite instability in yeast: dependence on repeat unit size and DNA mismatch repair genes , 1997, Molecular and cellular biology.

[10]  J. Morrow,et al.  Inhibition of human colon cancer cell growth by selective inhibition of cyclooxygenase-2. , 1997, The Journal of clinical investigation.

[11]  R. Fishel,et al.  MutS homologs in mammalian cells. , 1997, Current opinion in genetics & development.

[12]  Raymond L. White,et al.  Self-Promotion? Intimate Connections Between APC and Prostaglandin H Synthase-2 , 1996, Cell.

[13]  B. Rigas,et al.  Effects of nonsteroidal anti-inflammatory drugs on proliferation and on induction of apoptosis in colon cancer cells by a prostaglandin-independent pathway. , 1996, Biochemical pharmacology.

[14]  G. Colditz,et al.  Prospective study of regular aspirin use and the risk of breast cancer. , 1996, Journal of the National Cancer Institute.

[15]  R. Kolodner,et al.  Biochemistry and genetics of eukaryotic mismatch repair. , 1996, Genes & development.

[16]  M. Thun,et al.  NSAID use and decreased risk of gastrointestinal cancers. , 1996, Gastroenterology clinics of North America.

[17]  J. Eshleman,et al.  Diverse hypermutability of multiple expressed sequence motifs present in a cancer with microsatellite instability. , 1996, Oncogene.

[18]  B. Rigas,et al.  Nonsteroidal antiinflammatory drugs inhibit the proliferation of colon adenocarcinoma cells: effects on cell cycle and apoptosis. , 1996, Experimental cell research.

[19]  T. Kunkel,et al.  Microsatellite instability, mismatch repair deficiency, and genetic defects in human cancer cell lines. , 1995, Cancer research.

[20]  R. DuBois,et al.  Alterations in cellular adhesion and apoptosis in epithelial cells overexpressing prostaglandin endoperoxide synthase 2 , 1995, Cell.

[21]  E. Funkhouser,et al.  Aspirin and reduced risk of esophageal carcinoma , 1995, Cancer.

[22]  M. Kondo,et al.  Expression of cyclooxygenase-1 and -2 in human colorectal cancer. , 1995, Cancer research.

[23]  B. Rigas,et al.  Sulindac sulfide, an aspirin-like compound, inhibits proliferation, causes cell cycle quiescence, and induces apoptosis in HT-29 colon adenocarcinoma cells. , 1995, The Journal of clinical investigation.

[24]  R. Kolodner,et al.  Identification of mismatch repair genes and their role in the development of cancer. , 1995, Current opinion in genetics & development.

[25]  K. Kinzler,et al.  Mismatch repair deficiency in phenotypically normal human cells , 1995, Science.

[26]  D. Evans,et al.  Suggested Screening Guidelines for Familial Colorectal Cancer , 1995, Journal of medical screening.

[27]  J. Baron.  Aspirin and cancer. , 1995, Preventive medicine.

[28]  R. Fleischmann,et al.  Mutations of two P/WS homologues in hereditary nonpolyposis colon cancer , 1994, Nature.

[29]  E. Rimm,et al.  Aspirin Use and the Risk for Colorectal Cancer and Adenoma in Male Health Professionals , 1994, Annals of Internal Medicine.

[30]  M. Meuth,et al.  Mutator phenotypes in human colorectal carcinoma cell lines. , 1994, Proceedings of the National Academy of Sciences of the United States of America.

[31]  D. Ward,et al.  Mutation in the DNA mismatch repair gene homologue hMLH 1 is associated with hereditary non-polyposis colon cancer , 1994, Nature.

[32]  R. Everson,et al.  Aspirin Use and Lung, Colon, and Breast Cancer Incidence in a Prospective Study , 1994, Epidemiology.

[33]  N. Copeland,et al.  The human mutator gene homolog MSH2 and its association with hereditary nonpolyposis colon cancer , 1993, Cell.

[34]  N. Petrelli,et al.  Aspirin use, cancer, and polyps of the large bowel , 1993, Cancer.

[35]  Darryl Shibata,et al.  Ubiquitous somatic mutations in simple repeated sequences reveal a new mechanism for colonic carcinogenesis , 1993, Nature.

[36]  K. Kinzler,et al.  Clues to the pathogenesis of familial colorectal cancer. , 1993, Science.

[37]  S N Thibodeau,et al.  Microsatellite instability in cancer of the proximal colon. , 1993, Science.

[38]  M. Thun,et al.  Aspirin use and risk of fatal cancer. , 1993, Cancer research.

[39]  R. Hubert,et al.  Whole genome amplification from a single cell: implications for genetic analysis. , 1992, Proceedings of the National Academy of Sciences of the United States of America.

[40]  L. Loeb,et al.  Mutator phenotype may be required for multistage carcinogenesis. , 1991, Cancer research.

[41]  T. Mosmann.  Rapid colorimetric assay for cellular growth and survival: application to proliferation and cytotoxicity assays. , 1983, Journal of immunological methods.

[42]  H. Uk,et al.  Aspirin for reducing cancer metastases , 1977 .

[43]  B. Rigas,et al.  Effect of aspirin on induction of apoptosis in HT-29 human colon adenocarcinoma cells. , 1998, Biochemical pharmacology.

[44]  K. Tindall,et al.  Mutation rate at the hprt locus in human cancer cell lines with specific mismatch repair-gene defects. , 1997, Carcinogenesis.

[45]  T. Smyrk,et al.  An update of HNPCC (Lynch syndrome). , 1997, Cancer genetics and cytogenetics.

[46]  A D Carothers,et al.  Cancer risk associated with germline DNA mismatch repair gene mutations. , 1997, Human molecular genetics.